139 related articles for article (PubMed ID: 31195081)
1. Profound immunodeficiency with severe skin disease explained by concomitant novel CARMIL2 and PLEC1 loss-of-function mutations.
Maccari ME; Speckmann C; Heeg M; Reimer A; Casetti F; Has C; Ehl S; Castro CN
Clin Immunol; 2019 Nov; 208():108228. PubMed ID: 31195081
[TBL] [Abstract][Full Text] [Related]
2. Epidermolysis bullosa with late-onset muscular dystrophy and plectin deficiency.
Yiu EM; Klausegger A; Waddell LB; Grasern N; Lloyd L; Tran K; North KN; Bauer JW; McKelvie P; Chow CW; Ryan MM; Murrell DF
Muscle Nerve; 2011 Jul; 44(1):135-41. PubMed ID: 21674528
[TBL] [Abstract][Full Text] [Related]
3. Novel CARMIL2 Mutations in Patients with Variable Clinical Dermatitis, Infections, and Combined Immunodeficiency.
Alazami AM; Al-Helale M; Alhissi S; Al-Saud B; Alajlan H; Monies D; Shah Z; Abouelhoda M; Arnaout R; Al-Dhekri H; Al-Numair NS; Ghebeh H; Sheikh F; Al-Mousa H
Front Immunol; 2018; 9():203. PubMed ID: 29479355
[TBL] [Abstract][Full Text] [Related]
4. A human immunodeficiency syndrome caused by mutations in CARMIL2.
Schober T; Magg T; Laschinger M; Rohlfs M; Linhares ND; Puchalka J; Weisser T; Fehlner K; Mautner J; Walz C; Hussein K; Jaeger G; Kammer B; Schmid I; Bahia M; Pena SD; Behrends U; Belohradsky BH; Klein C; Hauck F
Nat Commun; 2017 Jan; 8():14209. PubMed ID: 28112205
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of exon 31 alternative splicing in phenotype and severity of epidermolysis bullosa caused by mutations in PLEC1.
Sawamura D; Goto M; Sakai K; Nakamura H; McMillan JR; Akiyama M; Shirado O; Oyama N; Satoh M; Kaneko F; Takahashi T; Konno H; Shimizu H
J Invest Dermatol; 2007 Jun; 127(6):1537-40. PubMed ID: 17273164
[No Abstract] [Full Text] [Related]
6. Complex Muco-cutaneous Manifestations of CARMIL2-associated Combined Immunodeficiency: A Novel Presentation of Dysfunctional Epithelial Barriers.
Marangi G; Garcovich S; Sante GD; Orteschi D; Frangella S; Scaldaferri F; Genuardi M; Peris K; Gurrieri F; Zollino M
Acta Derm Venereol; 2020 Jan; 100(1):adv00038. PubMed ID: 31709449
[No Abstract] [Full Text] [Related]
7. Novel compound heterozygous mutations in the plectin gene in epidermolysis bullosa with muscular dystrophy and the use of protein truncation test for detection of premature termination codon mutations.
Dang M; Pulkkinen L; Smith FJ; McLean WH; Uitto J
Lab Invest; 1998 Feb; 78(2):195-204. PubMed ID: 9484717
[TBL] [Abstract][Full Text] [Related]
8. A Novel CARMIL2 Mutation Resulting in Combined Immunodeficiency Manifesting with Dermatitis, Fungal, and Viral Skin Infections As Well as Selective Antibody Deficiency.
Atschekzei F; Jacobs R; Wetzke M; Sogkas G; Schröder C; Ahrenstorf G; Dhingra A; Ott H; Baumann U; Schmidt RE
J Clin Immunol; 2019 Apr; 39(3):274-276. PubMed ID: 31001706
[No Abstract] [Full Text] [Related]
9. Four novel plectin gene mutations in Japanese patients with epidermolysis bullosa with muscular dystrophy disclosed by heteroduplex scanning and protein truncation tests.
Takizawa Y; Shimizu H; Rouan F; Kawai M; Udono M; Pulkkinen L; Nishikawa T; Uitto J
J Invest Dermatol; 1999 Jan; 112(1):109-12. PubMed ID: 9886273
[TBL] [Abstract][Full Text] [Related]
10. A Unique Presentation of Infantile-Onset Colitis and Eosinophilic Disease without Recurrent Infections Resulting from a Novel Homozygous CARMIL2 Variant.
Kurolap A; Eshach Adiv O; Konnikova L; Werner L; Gonzaga-Jauregui C; Steinberg M; Mitsialis V; Mory A; Nunberg MY; Wall S; Shaoul R; Overton JD; ; Shuldiner AR; Zohar Y; Paperna T; Snapper SB; Shouval DS; Baris Feldman H
J Clin Immunol; 2019 May; 39(4):430-439. PubMed ID: 31079270
[TBL] [Abstract][Full Text] [Related]
11. Congenital muscular dystrophy, myasthenic symptoms and epidermolysis bullosa simplex (EBS) associated with mutations in the PLEC1 gene encoding plectin.
Forrest K; Mellerio JE; Robb S; Dopping-Hepenstal PJ; McGrath JA; Liu L; Buk SJ; Al-Sarraj S; Wraige E; Jungbluth H
Neuromuscul Disord; 2010 Nov; 20(11):709-11. PubMed ID: 20624679
[TBL] [Abstract][Full Text] [Related]
12. Congenital myasthenic syndrome associated with epidermolysis bullosa caused by homozygous mutations in PLEC1 and CHRNE.
Maselli RA; Arredondo J; Cagney O; Mozaffar T; Skinner S; Yousif S; Davis RR; Gregg JP; Sivak M; Konia TH; Thomas K; Wollmann RL
Clin Genet; 2011 Nov; 80(5):444-51. PubMed ID: 21175599
[TBL] [Abstract][Full Text] [Related]
13. Progress in epidermolysis bullosa: the phenotypic spectrum of plectin mutations.
Pfendner E; Rouan F; Uitto J
Exp Dermatol; 2005 Apr; 14(4):241-9. PubMed ID: 15810881
[TBL] [Abstract][Full Text] [Related]
14. Plectin and human genetic disorders of the skin and muscle. The paradigm of epidermolysis bullosa with muscular dystrophy.
Uitto J; Pulkkinen L; Smith FJ; McLean WH
Exp Dermatol; 1996 Oct; 5(5):237-46. PubMed ID: 8981021
[TBL] [Abstract][Full Text] [Related]
15. Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease.
Bosa L; Batura V; Colavito D; Fiedler K; Gaio P; Guo C; Li Q; Marzollo A; Mescoli C; Nambu R; Pan J; Perilongo G; Warner N; Zhang S; Kotlarz D; Klein C; Snapper SB; Walters TD; Leon A; Griffiths AM; Cananzi M; Muise AM
Sci Rep; 2021 Mar; 11(1):5945. PubMed ID: 33723309
[TBL] [Abstract][Full Text] [Related]
16. Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization.
McLean WH; Pulkkinen L; Smith FJ; Rugg EL; Lane EB; Bullrich F; Burgeson RE; Amano S; Hudson DL; Owaribe K; McGrath JA; McMillan JR; Eady RA; Leigh IM; Christiano AM; Uitto J
Genes Dev; 1996 Jul; 10(14):1724-35. PubMed ID: 8698233
[TBL] [Abstract][Full Text] [Related]
17. Epidermolysis bullosa: novel and de novo premature termination codon and deletion mutations in the plectin gene predict late-onset muscular dystrophy.
Rouan F; Pulkkinen L; Meneguzzi G; Laforgia S; Hyde P; Kim DU; Richard G; Uitto J
J Invest Dermatol; 2000 Feb; 114(2):381-7. PubMed ID: 10652002
[TBL] [Abstract][Full Text] [Related]
18. Plectin gene mutations can cause epidermolysis bullosa with pyloric atresia.
Pfendner E; Uitto J
J Invest Dermatol; 2005 Jan; 124(1):111-5. PubMed ID: 15654962
[TBL] [Abstract][Full Text] [Related]
19. Novel CARMIL2 (RLTPR) Mutation Presenting with Hyper-IgE and Eosinophilia: A Case Report.
Zamani R; Zoghi S; Shahkarami S; Seyedpour S; Jimenez Heredia R; Boztug K; Rezaei N
Endocr Metab Immune Disord Drug Targets; 2024; 24(5):596-605. PubMed ID: 37855284
[TBL] [Abstract][Full Text] [Related]
20. A Novel Pathogenic Variant in
Yonkof JR; Gupta A; Rueda CM; Mangray S; Prince BT; Rangarajan HG; Alshahrani M; Varga E; Cripe TP; Abraham RS
Front Immunol; 2020; 11():884. PubMed ID: 32625199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
